IS7548A - Methods for protecting epithelial and epithelial cells during chemotherapy - Google Patents

Methods for protecting epithelial and epithelial cells during chemotherapy

Info

Publication number
IS7548A
IS7548A IS7548A IS7548A IS7548A IS 7548 A IS7548 A IS 7548A IS 7548 A IS7548 A IS 7548A IS 7548 A IS7548 A IS 7548A IS 7548 A IS7548 A IS 7548A
Authority
IS
Iceland
Prior art keywords
epithelial
methods
protecting
cells during
during chemotherapy
Prior art date
Application number
IS7548A
Other languages
Icelandic (is)
Inventor
Eissner Guenther
Holler Ernst
Original Assignee
Klinikum Der Universitaet Regensburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinikum Der Universitaet Regensburg filed Critical Klinikum Der Universitaet Regensburg
Publication of IS7548A publication Critical patent/IS7548A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
IS7548A 2002-05-31 2004-11-24 Methods for protecting epithelial and epithelial cells during chemotherapy IS7548A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38411402P 2002-05-31 2002-05-31
US38743802P 2002-06-11 2002-06-11
PCT/EP2003/005753 WO2003101468A1 (en) 2002-05-31 2003-06-02 Method for the protection of endothelial and epithelial cells during chemotherapy

Publications (1)

Publication Number Publication Date
IS7548A true IS7548A (en) 2004-11-24

Family

ID=29715309

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7548A IS7548A (en) 2002-05-31 2004-11-24 Methods for protecting epithelial and epithelial cells during chemotherapy

Country Status (16)

Country Link
EP (1) EP1509235A1 (en)
JP (1) JP2005527636A (en)
CN (1) CN1304011C (en)
AU (1) AU2003238189A1 (en)
CA (1) CA2487171A1 (en)
EA (1) EA008213B1 (en)
HR (1) HRP20041213A2 (en)
IL (1) IL165353A0 (en)
IS (1) IS7548A (en)
MX (1) MXPA04011941A (en)
NO (1) NO20045655L (en)
NZ (1) NZ536864A (en)
PL (1) PL374402A1 (en)
RS (1) RS102504A (en)
UA (1) UA83628C2 (en)
WO (1) WO2003101468A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031714A1 (en) 2003-09-05 2005-03-06 Gentium Spa FORMATIONS FOR ANTITUMORAL ACTION.
EP2637672B1 (en) * 2010-11-12 2018-08-22 Gentium S.r.l. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
ES2660969T5 (en) 2012-06-22 2021-09-03 Gentium S R L Euglobulin-based method to determine the biological activity of defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU754242B2 (en) * 1997-04-28 2002-11-07 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof

Also Published As

Publication number Publication date
MXPA04011941A (en) 2005-07-26
CN1655801A (en) 2005-08-17
NO20045655L (en) 2004-12-27
PL374402A1 (en) 2005-10-17
NZ536864A (en) 2008-08-29
WO2003101468A1 (en) 2003-12-11
JP2005527636A (en) 2005-09-15
EA200401448A1 (en) 2005-06-30
IL165353A0 (en) 2006-01-15
AU2003238189A1 (en) 2003-12-19
HRP20041213A2 (en) 2006-04-30
EP1509235A1 (en) 2005-03-02
UA83628C2 (en) 2008-08-11
CN1304011C (en) 2007-03-14
CA2487171A1 (en) 2003-12-11
RS102504A (en) 2006-12-15
EA008213B1 (en) 2007-04-27

Similar Documents

Publication Publication Date Title
EP1537585A4 (en) CELL
DE60330151D1 (en) FUEL CELL SYSTEM
DE10324396A8 (en) fuel cell
DE60316596D1 (en) FUEL CELL SYSTEM
DE60326112D1 (en) The fuel cell system
NO20031285L (en) The insulation bypass overgangsskjöt
DE60331474D1 (en) FUEL CELL SYSTEM
DE602004026708D1 (en) FUEL CELL SYSTEM
NO20032504L (en) sealant
DE60331959D1 (en) FUEL CELL SYSTEM
DE60329024D1 (en) FUEL CELL
DE60207518D1 (en) attenuator
DE50303161D1 (en) Centering
DE60303345D1 (en) fuel cell
IS7826A (en) Electrolyte leakage leakage
DE60321289D1 (en) The fuel cell system
DE60323022D1 (en) fuel cell
DE60312367D1 (en) FUEL CELL SYSTEM
DE502004008433D1 (en) CELL
IS7548A (en) Methods for protecting epithelial and epithelial cells during chemotherapy
DK1768691T3 (en) Aequorin-containing preparations and methods for using the same
DE60314807D1 (en) sealing device
DE60329145D1 (en) sealing device
FR2834557B1 (en) OCEANIC SPACE STATION
EP1515386A4 (en) FUEL CELL